FI930220L - OLIGONUCLEOTIDE ANALOGER, DERAS FRAMSTAELLNING OCH ANVAENDNING - Google Patents

OLIGONUCLEOTIDE ANALOGER, DERAS FRAMSTAELLNING OCH ANVAENDNING Download PDF

Info

Publication number
FI930220L
FI930220L FI930220A FI930220A FI930220L FI 930220 L FI930220 L FI 930220L FI 930220 A FI930220 A FI 930220A FI 930220 A FI930220 A FI 930220A FI 930220 L FI930220 L FI 930220L
Authority
FI
Finland
Prior art keywords
analoger
oligonucleotide
deras framstaellning
framstaellning och
och anvaendning
Prior art date
Application number
FI930220A
Other languages
Finnish (fi)
Other versions
FI930220A0 (en
FI115214B (en
Inventor
Eugen Uhlmann
Anuschirwan Peyman
Gerard O'malley
Matthias Helsberg
Irvin Winkler
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI930220A0 publication Critical patent/FI930220A0/en
Publication of FI930220L publication Critical patent/FI930220L/en
Application granted granted Critical
Publication of FI115214B publication Critical patent/FI115214B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
FI930220A 1992-01-22 1993-01-20 Process for Preparation of Oligonucleotide Analogs and Their Use FI115214B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4201662 1992-01-22
DE4201662 1992-01-22

Publications (3)

Publication Number Publication Date
FI930220A0 FI930220A0 (en) 1993-01-20
FI930220L true FI930220L (en) 1993-07-23
FI115214B FI115214B (en) 2005-03-31

Family

ID=6450030

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930220A FI115214B (en) 1992-01-22 1993-01-20 Process for Preparation of Oligonucleotide Analogs and Their Use

Country Status (17)

Country Link
EP (1) EP0552766B1 (en)
JP (1) JP3717081B2 (en)
KR (1) KR930016437A (en)
AT (1) ATE217880T1 (en)
AU (1) AU661365B2 (en)
CA (1) CA2087818C (en)
DE (1) DE59310285D1 (en)
DK (1) DK0552766T3 (en)
ES (1) ES2177532T3 (en)
FI (1) FI115214B (en)
HU (1) HU227794B1 (en)
IL (1) IL104461A (en)
NO (1) NO308215B1 (en)
NZ (1) NZ245720A (en)
PL (1) PL172257B1 (en)
PT (1) PT552766E (en)
ZA (1) ZA93422B (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5646261A (en) * 1992-01-22 1997-07-08 Hoechst Aktiengesellschaft 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
DK0593901T3 (en) * 1992-09-24 1997-10-27 Hoechst Ag Oligoribonucleotide and ribozyme analogs with terminal 3-3 and 5-5 bonds.
EP0602524A1 (en) * 1992-12-15 1994-06-22 Hoechst Aktiengesellschaft Chemiluminescence marked sequences and their use in sequence testing
ATE150464T1 (en) * 1993-01-08 1997-04-15 Hybridon Inc SYNTHESIS OF DIMER BLOCKS AND THEIR USE IN THE COMPOSITION OF OLIGONUCLEOTIDES
US6087491A (en) 1993-01-08 2000-07-11 Hybridon, Inc. Extremely high purity oligonucleotides and methods of synthesizing them using dimer blocks
DK0677056T3 (en) * 1993-01-25 1996-08-05 Hybridon Inc Oligonucleotide alkyl phosphonates and alkyl phosphonothioates
CA2114355A1 (en) * 1993-01-29 1994-07-30 Hidehiko Furukawa Modified oligodeoxyribonucleotides, their preparation and their therapeutic use
US5532130A (en) * 1993-07-20 1996-07-02 Dyad Pharmaceutical Corporation Methods and compositions for sequence-specific hybridization of RNA by 2'-5' oligonucleotides
DE4331670A1 (en) * 1993-09-17 1995-03-23 Hoechst Ag Antisense oligonucleotides against HSV-1 and the preparation thereof
DE4338704A1 (en) 1993-11-12 1995-05-18 Hoechst Ag Stabilized oligonucleotides and their use
DE4408528A1 (en) * 1994-03-14 1995-09-28 Hoechst Ag Peptide oligonucleotide derivatives, their preparation and use
US6919441B2 (en) 1994-03-14 2005-07-19 Aventis Pharma Deutschland Gmbh Polyamide-oligonucleotide derivatives, their preparation and use
HUT76094A (en) * 1994-03-18 1997-06-30 Lynx Therapeutics Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
US5599922A (en) * 1994-03-18 1997-02-04 Lynx Therapeutics, Inc. Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties
US5726297A (en) * 1994-03-18 1998-03-10 Lynx Therapeutics, Inc. Oligodeoxyribonucleotide N3' P5' phosphoramidates
DE4415370A1 (en) * 1994-05-02 1995-11-09 Hoechst Ag Modified oligonucleotides, their preparation and their use
US5986076A (en) * 1994-05-11 1999-11-16 Trustees Of Boston University Photocleavable agents and conjugates for the detection and isolation of biomolecules
US5696248A (en) * 1994-06-15 1997-12-09 Hoechst Aktiengesellschaft 3'-modified oligonucleotide derivatives
DE4438918A1 (en) * 1994-11-04 1996-05-09 Hoechst Ag Modified oligonucleotides, their preparation and their use
US6150510A (en) 1995-11-06 2000-11-21 Aventis Pharma Deutschland Gmbh Modified oligonucleotides, their preparation and their use
DE19502912A1 (en) * 1995-01-31 1996-08-01 Hoechst Ag G-Cap Stabilized Oligonucleotides
PT739898E (en) * 1995-03-13 2002-03-28 Aventis Pharma Gmbh PHOSPHONUCLETIC ACID MONO-ESTERS PROCESS FOR PREPARING AND USING
US6326487B1 (en) 1995-06-05 2001-12-04 Aventis Pharma Deutschland Gmbh 3 modified oligonucleotide derivatives
US5684143A (en) * 1996-02-21 1997-11-04 Lynx Therapeutics, Inc. Oligo-2'-fluoronucleotide N3'->P5' phosphoramidates
US5859233A (en) * 1996-02-21 1999-01-12 Lynx Therapeutics, Inc. Synthons for synthesis of oligonucleotide N3-P5 phosphoramidates
GB9606158D0 (en) * 1996-03-23 1996-05-29 Ciba Geigy Ag Chemical compounds
ES2221942T3 (en) * 1996-05-24 2005-01-16 Aventis Pharma Deutschland Gmbh REAGENT AND METHOD TO INHIBIT THE EXPRESSION OF N-RAS.
DE19627898A1 (en) * 1996-07-11 1998-01-15 Hoechst Ag Solid phase synthesis of oligonucleotides
US6723706B2 (en) 1997-05-05 2004-04-20 Aventis Pharma Deutschland Gmbh Modified antisense nucleotides complementary to a section of the human Ha-ras gene
AU9460898A (en) * 1997-10-14 1999-05-03 Sankyo Company Limited Modified oligodeoxyribonucleotides having tggg sequence
EP1004661A1 (en) 1998-11-11 2000-05-31 DALLI-WERKE WÄSCHE- und KÖRPERPFLEGE GmbH & Co. KG High density granule, method for production thereof, and its use as disintegrant in tablets
DE19935303A1 (en) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonucleotides to inhibit the expression of human eg5
DE19935302A1 (en) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Conjugates and processes for their preparation and their use for the transport of molecules across biological membranes
DE10133915A1 (en) 2001-07-12 2003-02-06 Aventis Pharma Gmbh New oligoribonucleotide derivatives for targeted inhibition of gene expression
CN1845993B (en) 2003-08-28 2010-06-23 诺瓦提斯公司 Interfering RNA duplexes with blunt ends and 3' modifications
GB0608838D0 (en) 2006-05-04 2006-06-14 Novartis Ag Organic compounds
EP3643782A1 (en) 2008-02-11 2020-04-29 Phio Pharmaceuticals Corp. Modified rnai polynucleotides and uses thereof
US8815818B2 (en) 2008-07-18 2014-08-26 Rxi Pharmaceuticals Corporation Phagocytic cell delivery of RNAI
EP2342340A1 (en) 2008-09-22 2011-07-13 Rxi Pharmaceuticals Corporation Rna interference in skin indications
US9074211B2 (en) 2008-11-19 2015-07-07 Rxi Pharmaceuticals Corporation Inhibition of MAP4K4 through RNAI
WO2010090762A1 (en) 2009-02-04 2010-08-12 Rxi Pharmaceuticals Corporation Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
WO2011119852A1 (en) 2010-03-24 2011-09-29 Rxi Pharmaceuticals Corporation Reduced size self-delivering rnai compounds
CA2794189C (en) 2010-03-24 2022-01-11 Rxi Pharmaceuticals Corporation Rna interference in dermal and fibrotic indications
US9095504B2 (en) 2010-03-24 2015-08-04 Rxi Pharmaceuticals Corporation RNA interference in ocular indications
JP6772062B2 (en) 2013-12-02 2020-10-21 フィオ ファーマシューティカルズ コーポレーションＰｈｉｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐ． Cancer immunotherapy
WO2015125845A1 (en) * 2014-02-20 2015-08-27 塩野義製薬株式会社 Phosphate site modification of nucleic acid containing nitrogen-containing non-aromatic heterocycle
CA2947270A1 (en) 2014-04-28 2015-11-05 Rxi Pharmaceuticals Corporation Methods for treating cancer using nucleic acids targeting mdm2 or mycn
EP3188799B1 (en) 2014-09-05 2022-07-06 Phio Pharmaceuticals Corp. Methods for treating aging and skin disorders using nucleic acids targeting tyr or mmp1
US11001845B2 (en) 2015-07-06 2021-05-11 Phio Pharmaceuticals Corp. Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)
US10808247B2 (en) 2015-07-06 2020-10-20 Phio Pharmaceuticals Corp. Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
US11021707B2 (en) 2015-10-19 2021-06-01 Phio Pharmaceuticals Corp. Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA
JP7167059B2 (en) 2017-04-19 2022-11-08 フィオ ファーマシューティカルズ コーポレーション Local delivery of nucleic acid compounds
CA3098623A1 (en) 2018-05-07 2019-11-14 Alnylam Pharmaceuticals, Inc. Extrahepatic delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3239888A1 (en) * 1982-10-28 1984-05-03 Hubert Prof. Dr. 2000 Hamburg Köster METHOD FOR PRODUCING OLIGONUCLEOSIDE PHOSPHONATES
US4739044A (en) * 1985-06-13 1988-04-19 Amgen Method for derivitization of polynucleotides
US4950745A (en) * 1986-10-30 1990-08-21 Daicel Chemical Industries, Ltd. Process for synthesis of oligonucleotides and compound for forming polymeric protecting group
US4816571A (en) * 1987-06-04 1989-03-28 Applied Biosystems, Inc. Chemical capping by phosphitylation during oligonucleotide synthesis
WO1991006556A1 (en) * 1989-10-24 1991-05-16 Gilead Sciences, Inc. 2' modified oligonucleotides
US5210015A (en) * 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
GB9021625D0 (en) * 1990-10-04 1990-11-21 Ici Plc Synthesis of oligonucleotides

Also Published As

Publication number Publication date
DE59310285D1 (en) 2002-06-27
PL172257B1 (en) 1997-08-29
CA2087818C (en) 2007-07-10
NO930199L (en) 1993-07-23
DK0552766T3 (en) 2002-08-19
AU661365B2 (en) 1995-07-20
IL104461A (en) 2001-05-20
PL297515A1 (en) 1993-09-06
ES2177532T3 (en) 2002-12-16
EP0552766A2 (en) 1993-07-28
FI930220A0 (en) 1993-01-20
ATE217880T1 (en) 2002-06-15
NZ245720A (en) 1995-12-21
EP0552766B1 (en) 2002-05-22
PT552766E (en) 2002-10-31
KR930016437A (en) 1993-08-26
JP3717081B2 (en) 2005-11-16
HU9300162D0 (en) 1993-04-28
NO930199D0 (en) 1993-01-21
ZA93422B (en) 1993-09-16
AU3191093A (en) 1993-07-29
HUT63173A (en) 1993-07-28
HU227794B1 (en) 2012-03-28
FI115214B (en) 2005-03-31
IL104461A0 (en) 1993-05-13
JPH05310779A (en) 1993-11-22
NO308215B1 (en) 2000-08-14
EP0552766A3 (en) 1994-09-07
CA2087818A1 (en) 1993-07-23

Similar Documents

Publication Publication Date Title
FI933857A7 (en) Kondenserade heterocykliska foereningar, deras framstaellning och anvaendning
FI934274L (en) N-SULFONYL-2-OXI-INDOLDERIVAT, DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE FARMACEUTISKA KOMPOSITIONER
FI931608L (en) FOERFARANDE OCH ANORDNING FOER THERAPEUTISK, ELEKTROMAGNETISK BEHANDLING
FI931901L (en) AZOLFOERENINGAR, DERAS FRAMSTAELLNING OCH ANVAENDNING
FI931305A7 (en) IMIDAZOLFOERENINGAR, DERAS FRAMSTAELLNING OCH BRUK
FI933942L (en) Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande Foer deras framstaellning
FI930620A0 (en) BENSIMIDAZOLYLDERIVAT, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI931190A7 (en) TRIAZOLOPYRIDAZINFOERENINGAR, DERAS FRAMSTAELLNING OCH ANVAENDNING
FI930711L (en) NAFTALENDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS SYNTETISK MELLANPRODUKTER
FI932649L (en) BIPHENYLDERIVAT, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDEFOER DERAS FRAMSTAELLNING
FI932660L (en) VAERMEFOERSEGLINGSBARA, ANTISTATISKA BELAGDA FOLIER OCH FOLIELAMINAT, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA
FI930977L (en) TAXANDERIVAT, DERAS FRAMSTAELLNING OCH ONKOLOGISKA ANVAENDNING
FI933903A7 (en) Substituerade cyklohexanerivat, foerfarande Foer framstaellning daerav och anvaendning av foereningar Foer behandling av sikdoek
FI930974L (en) SUBSTITUERADE AMINOPHOSPHONATDERIVAV, FOERFARANDE FOER FRAMSTAELLNING AV DESAMMA OCH FARMACEUTISKA KOMPOSITIONER INNEHAOLLANDE DESAMMA
FI931291L (en) INDOL- OCH INDAZOLDERIVAT FOER BEHANDLING OCH FOEREBYGGANDE AV HJAERNSJUKDOMAR, DERAS FRAMSTAELLNING OCH ANVAENDNING
FI922004A0 (en) MAETNINGSFOERFARANDE OCH MAETANORDNING.
FI935829A0 (en) Anlaeggning och foerfarande Foer uttnyttjning av braennbara aemnen, speciellt industri- ocus hushaollsavfall
FI931599L (en) BENSIMIDAZOLER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDEFOER DERAS FRAMSTAELLNING
FI930130L (en) BUNDET FIBERKNIPPE, FOERFARANDE FOER FRAMSTAELLNING AV DETTA OCH DAERAV ERHAOLNA TEXTILYTSTRUKTURER
FI930717A7 (en) 4-AMINO-2-UREIDO-PYRIMIDIN-5-CARBOXYLCYRAMIDER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA, LAEKEMEDEL INNEHAOLLANDE DESSA OCH DERAS ANVAENDNING
FI931682A0 (en) TACKYKININRECEPTORANTAGONISTER, ISOKINOLONER OCH DERAS FRAMSTAELLNING
FI934221A0 (en) PIPERIDINDERIVAT, FRAMSTAELLNING OCH TERAPEUTISK ANVAENDNING DAERAV
FI932951L (en) TILLSATSKONCENTRAT INNEHAOLLANDE SULFURERAT JORDALKALIMETALLHYDROCARBYLFENAT, FOERFARANDE FOER FRAMSTAELLNING AV DETTA OCH ANVAENDNING AV DETTA
FI930236L (en) BENSIMIDAZOLER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDEFOER DERAS FRAMSTAELLNING
FI931881L (en) MAERKTA FIBRINOGEN-RESEPTO-ANTAGONISTER, DERAS ANVAENDNING OCH FOERFARANDE FOER DERAS FRAMSTAELLNING

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115214

Country of ref document: FI

MA Patent expired